HER2 0, HER2 1+and HER2 2+/FISH Negative Breast Cancers Are Biologically Different

被引：0
|
作者：
Mon, Khin Su [1 ]
Zhang, Hui [1 ]
Aragao, Alessa [2 ]
Tang, Ping [1 ]
机构：
[1] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[2] Mayo Clin, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
193
引用
收藏
页码：S182 / S183
页数：2
相关论文
共 50 条
  • [1] HER2 0, HER2 1+and HER2 2+/FISH Negative Primary Breast Cancers Are Biologically Distinct
    Donahue, Nolan
    Aragao, Alessa
    Gordezky, Rachel
    Haddad, Sandra
    Tang, Ping
    LABORATORY INVESTIGATION, 2024, 104 (03) : S146 - S148
  • [2] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [3] HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX
    Tozbikian, Gary H.
    Zynger, Debra L.
    BREAST JOURNAL, 2018, 24 (04): : 535 - 540
  • [4] Activating HER2 mutations in HER2 gene amplification negative breast cancers.
    Bose, R.
    Kavuri, S. M.
    Searleman, A. C.
    Shen, W.
    Shen, D.
    Koboldt, D. C.
    Monsey, J.
    Li, S.
    Ding, L.
    Mardis, E. R.
    Ellis, M. J.
    CANCER RESEARCH, 2012, 72
  • [5] Her2 FISH amplification in ER/PR/Her2 IHC negative breast cancer
    Sahoo, Sunati
    Hwang, Helena
    CANCER RESEARCH, 2015, 75
  • [6] HER2 or not HER2: That is the question
    Burstein, HJ
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3656 - 3659
  • [7] Reassessment of HER2 status in HER2 negative or HER2 unknown breast cancer patients with recurrent metastatic disease by analyzing serum HER2 and HER2 status of circulating tumor cells.
    Fehm, T.
    Lane, N.
    Solomayer, E.
    Wallwiener, D.
    Uhr, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [8] Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
    Lee, Andrew H. S.
    Key, Heather P.
    Bell, Jane A.
    Hodi, Zsolt
    Ellis, Ian O.
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (06) : 490 - 492
  • [9] Correlation of HER2 Immunohistochemical Scores and HER2 mRNA, Oncotype Recurrence Score and Magee Scores on ER Positive, HER2 Negative Breast Cancers
    Tyburski, Haley
    Karakas, Cansu
    Zhang, Huina
    Liu, Elena
    Turner, Bradley
    Hicks, David
    LABORATORY INVESTIGATION, 2023, 103 (03) : S216 - S217
  • [10] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
12345